Palivizumab was the only approved therapy to prevent severe RSV disease in infants and young children until the approval of nirsevimab in 2023.

Inpatient mortality and adverse outcomes were significantly more likely among adults hospitalized with RSV infection vs seasonal influenza.

Central Texas doctor's offices and care centers have noticed the annual summer COVID-19 spike in cases has been happening in ...

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in ...

A COVID-19 outbreak has been reported at Hillcrest Home in Geneseo. Health officials said symptoms are relatively mild for ...

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in treatment for cancers, rare disease and more.

From poor air quality to food safety, travel can make you sick. MeritusNow shares tips to reduce your risk and stay well on ...

The Guam Department of Public Health and Social Services has confirmed an uptick in respiratory viral activity on the island, ...

The NHS is urging pregnant women to safeguard themselves and their babies by getting vaccinated against potentially deadly viruses.

Biotechnology company Moderna (NASDAQ:MRNA) announced better-than-expected revenue in Q2 CY2025, but sales fell by 41.1% year ...

Pulling the Pfizer EUA would remove the only COVID-19 vaccine approved for all children from the US market. The Moderna ...

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced last week that his department would slash about $500 ...